(3,3,5-trimethylcyclohexyl) 2-hydroxy-2-phenylacetate;(3,3,5-trimethylcyclohexyl) 2-hydroxy-2-phenyl-acetate;2-hydroxy-2-phenylacetic acid (3,3,5-trimethylcyclohexyl) ester;2-hydroxy-2-phenyl-acetic acid (3,3,5-trimethylcyclohexyl) ester;(3,3,5-trimethylcyclohexyl) 2-hydroxy-2-phenyl-ethanoate;28283-32-1;456-59-7;54110-27-9;3,3,5-Trimethylcyclohexanol alpha-phenyl-alpha-hydroxyacetate;3,3,5-Trimethylcyclohexyl mandelate;3,5,5-Trimethylcyclohexanol, mandelic acid ester;3,5,5-Trimethylcyclohexyl amygdalate;3,5,5-Trimethylcyclohexyl mandelate;Arto-espasmol;BS 572;Benzeneacetic acid, alpha-hydroxy-, 3,3,5-trimethylcyclohexyl ester;CYCLANDELATE;Capilan;Ciclandelato [INN-Spanish];Ciclospasmol;Clandilon;Cyclandelate [BAN:INN:JAN];Cyclandelatum [INN-Latin];Cyclolyt;Cyclomandol;Cyclospasmol;Dilatan;EINECS 207-271-6;HSDB 3046;Mandelic acid, 3,3,5-trimethylcyclohexyl ester;Perebral;Saiclate;Sancyclan;Sepyron;Spasmione;Spasmocyclon;Spasmocyclone;alpha-Hydroxybenzeneacetic acid 3,3,5-trimethylcyclohexyl ester;AIDS-166744;AIDS166744;(3,3,5-trimethylcyclohexyl) 2-hydroxy-2-phenylacetate;Cyclospasmol (TN);D00286;3,3,5-trimethylcyclohexyl hydroxy(phenyl)acetate;ST5448573;Benzeneacetic acid, .alpha.-hydroxy-, 3,3,5-trimethylcyclohexyl ester;NCGC00159506-02;NCGC00159506-03;Cyclandelate (JAN/USP/INN)
(3,3,5-trimethylcyclohexyl) 2-hydroxy-2-phenylacetate